Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity is a research paper published in Cancer Cell (2022). On theSindex it has a DataRank of 4.7. It has been cited 350 times, with 100 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.879
From this paper's citation signal
Citation Network Contribution
3.9
From 100 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 100 citers.
Cancer Prevention and Research Institute of Texas
Grant: K08AR079587
Cancer Prevention and Research Institute of Texas
Grant: P30CA016672
Cancer Prevention and Research Institute of Texas
Grant: RP190326
Cancer Prevention and Research Institute of Texas
Grant: UT MDACC CA016672
Foundation for the National Institutes of Health
Grant: R01HL141966
Foundation for the National Institutes of Health
Grant: R01HL143520
National Institutes of Health
Grant: K01AI163412
National Institutes of Health
Grant: P50CA221703
FWCI
29.57
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals